massive buy, page-32

Boiler prr has been at it for a long time.They are years ahead of many in this area of research(a point I think has been missed).
Any new research projects into any cancer treatment(as was reported earlier in the year with a NQ tropical bush/a dog responding) takes many years to get through the processes required to get an acceptable treatment,let alone a markatable product.
More specific and related to CVac,immunology was the buzz word in cancer treatment research in the 80's and early 90's after which it lost some favour.Less work was done in the area as other waters were tested. So now Prr finds itself in the box seat as immunolgical reserach and treatments are now showing to have greater success or at least have resurfaced in the eyes of the scientic community.
So why is it in the box seat?

Its years down the track and into final testing stages just when there is a new interest into immunolgical treatments for cancer.......LUCKY

Another company doing a similar thing in America(Dndn) has done a lot of hard(and very,very expensive)work to get their product to market.So Prr can ride their Slipstream.....LUCKY

It has been shown that prr's treatment may also be useful to a wider variety of cancers.Bigger market

Prr has strong and extensive patents.It has US/European ODS which gives a longer life.

A well balanced management team.While the "science" was always very strong it now has strong business contacts through the appointment of Ms Turnball.Mr Rogers has married the science and business world well.

Proposed listing on Nasdaq is timely.With US investors not only beying exposed to prr,but already comparing it to dndn

Financing is in the bag.Most Australian small caps like Prr fall over on the bigger stage because they starve.While the existing arrangement is not perfect,That would change with a higher market cap.

Good luck to holders and all cancer victims